Hebei Lansheng Biotech Co., Ltd.
ShangHai Yuelian Biotech Co., Ltd.

Wynca subsidiary’s annual 6,000-ton glufosinate project expected to enter trial production by year’s endqrcode

Jul. 21, 2021

Favorites Print
Forward
Jul. 21, 2021

2021-02.png

Make Virtual Participation to follow up the supply dynamics and make right procurement strategy! 


Recently, on an investment platform of China, Wynca was asked about its glufosinate capacity.


The company replied that its subsidiary, Wynca Ningxia, is implementing an annual 6,000-ton glufosinate project, which includes intermediate diethyl ester. Phase I of the project, covering 3,000 tons glufosinate inclusive of diethyl annually, is expected to enter trial production by the end of 2021.


QQ截图20210303155608.pngQQ截图20210303155617.png


Picture 0/1200

More from AgroNews

Magazine

2021 Market Insight 2021 India Pesticide Suppliers Guide
2021 CRO & CRAO Manual 2021 Latin America Focus
2021 Seed Treatment Special 2021 Biologicals Special
I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

Picture 0/1200

Subscribe to daily email alerts of AgroNews.